Functional Biomarkers for Amyotrophic Lateral Sclerosis
The clinical diagnosis of amyotrophic lateral sclerosis (ALS) relies on determination of progressive dysfunction of both cortical as well as spinal and bulbar motor neurons. However, the variable mix of upper and lower motor neuron signs result in the clinical heterogeneity of patients with ALS, res...
Main Authors: | William Huynh, Thanuja Dharmadasa, Steve Vucic, Matthew C. Kiernan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2018.01141/full |
Similar Items
-
Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets
by: Kazumoto Shibuya, et al.
Published: (2022-03-01) -
The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations
by: Andrew Eisen, et al.
Published: (2025-02-01) -
Diagnostic utility of transcranial magnetic stimulation for neurodegenerative disease: a critical review
by: Javier Moreno-Roco, et al.
Published: (2024-01-01) -
Utility of Transcranial Magnetic Simulation in Studying Upper Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis
by: Nimeshan Geevasinga, et al.
Published: (2021-07-01) -
Neurophysiological testing in the diagnosis of amyotrophic lateral sclerosis
by: David Burke
Published: (2022-01-01)